152 related articles for article (PubMed ID: 29223489)
1. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants.
Korkmaz L; Baştuğ O; Özdemir A; Korkut S; Karaca Ç; Akın MA; Öztürk MA
Pediatr Neonatol; 2018 Oct; 59(5):455-463. PubMed ID: 29223489
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index.
Korkmaz L; Baştuğ O; Ozdemir A; Korkut S; Karaca C; Akin MA; Gunes T; Kurtoglu S; Ozturk MA
Curr Eye Res; 2017 Jan; 42(1):88-97. PubMed ID: 27260268
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytopenia is associated with severe retinopathy of prematurity.
Cakir B; Liegl R; Hellgren G; Lundgren P; Sun Y; Klevebro S; Löfqvist C; Mannheimer C; Cho S; Poblete A; Duran R; Hallberg B; Canas J; Lorenz V; Liu ZJ; Sola-Visner MC; Smith LE; Hellström A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282834
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
[TBL] [Abstract][Full Text] [Related]
5. Impact of Platelet Count in Retinopathy of Prematurity.
Şahinoğlu Keşkek N; Gülcan H; Yılmaz G; Akkoyun İ
Turk J Ophthalmol; 2020 Dec; 50(6):351-355. PubMed ID: 33389935
[TBL] [Abstract][Full Text] [Related]
6. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?
Ozturk MA; Korkmaz L
Int Ophthalmol; 2019 Sep; 39(9):1921-1930. PubMed ID: 30229439
[TBL] [Abstract][Full Text] [Related]
8. Optimizing Measurement of Vascular Endothelial Growth Factor in Small Blood Samples of Premature Infants.
Lopez Yomayuza CC; Preissner KT; Lorenz B; Stieger K
Sci Rep; 2019 May; 9(1):6744. PubMed ID: 31043645
[TBL] [Abstract][Full Text] [Related]
9. The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.
Özkaya D
Int J Clin Pract; 2022; 2022():7518533. PubMed ID: 35685577
[TBL] [Abstract][Full Text] [Related]
10. Potential contribution of mobilized circulating endothelial progenitor cells to development of retinal neovascularization in preterm infants with ROP.
Machalińska A; Modrzejewska M; Kawa M; Paczkowska E; Dziedziejko V; Safranow K; Lubiński W; Machaliński B
Klin Oczna; 2013; 115(3):194-8. PubMed ID: 24745090
[TBL] [Abstract][Full Text] [Related]
11. Increased circulation mobilization of endothelial progenitor cells in preterm infants with retinopathy of prematurity.
Babaei H; Alibabrdel M; Asadian S; Siavashi V; Jabarpour M; Nassiri SM
J Cell Biochem; 2018 Aug; 119(8):6575-6583. PubMed ID: 29737539
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
[TBL] [Abstract][Full Text] [Related]
13. Nucleated red blood cells in preterm infants with retinopathy of prematurity.
Lubetzky R; Stolovitch C; Dollberg S; Mimouni FB; Salomon M; Mandel D
Pediatrics; 2005 Nov; 116(5):e619-22. PubMed ID: 16199672
[TBL] [Abstract][Full Text] [Related]
14. The effects of thyroid function on retinopathy of prematurity.
Korkmaz L; Baştuğ O; Daar G; Korkut S; Özdemir A; Adnan Öztürk M; Güneş T; Kurtoğlu S
J Neonatal Perinatal Med; 2016; 9(4):349-356. PubMed ID: 28009339
[TBL] [Abstract][Full Text] [Related]
15. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.
Huang CY; Lien R; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):479-487. PubMed ID: 29290015
[TBL] [Abstract][Full Text] [Related]
16. Relationship between mean platelet volume and retinopathy of prematurity.
Tao Y; Dong Y; Lu CW; Yang W; Li Q
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1791-4. PubMed ID: 25749720
[TBL] [Abstract][Full Text] [Related]
17. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
Kandasamy Y; Hartley L; Rudd D; Smith R
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
[TBL] [Abstract][Full Text] [Related]
19. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
Huang ZN; Yin DM; Huang DR; Liang SX
Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity.
Peirovifar A; Gharehbaghi MM; Gharabaghi PM; Sadeghi K
Singapore Med J; 2013 Dec; 54(12):709-12. PubMed ID: 24356758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
